Strontium Acetate

What it is

Strontium acetate is the strontium salt of acetic acid, Sr(CH₃COO)₂, CAS 543-94-2. It is the modern, fast-acting strontium form used to treat dentine hypersensitivity. Strontium acetate at 8% is the active in Sensodyne Rapid Action, the line that claims relief "in 60 seconds".

Strontium is a divalent cation (Sr²⁺) chemically similar to calcium: the ionic radius of strontium (around 118 pm) is very close to that of calcium (around 100 pm), so strontium can take up calcium sites in the hydroxyapatite lattice. This similarity is the foundation of its entire mode of action.

The historical first strontium form in sensitivity toothpastes was 10% strontium chloride (the classic Sensodyne Original, launched back in the 1960s). The switch to acetate delivered a faster onset at a lower concentration, which is why acetate has replaced chloride in modern instant-relief formulations.

How it works

Strontium acetate acts through dentinal tubule occlusion — it physically seals the open tubules that lead to the nerve endings in the pulp. This sets it apart from the nerve-blocking potassium salts, which depolarise the nerve but do not close the tubules.

Step by step: Sr²⁺ ions ionically substitute for calcium in hydroxyapatite, forming strontium-substituted apatite right at the mouth and inside the lumen of the tubule. A mineral plug forms that resists rinsing away. Because strontium incorporates into the same apatite lattice as the dentine's own mineral, the plug integrates with the tissue rather than simply sitting on top.

Dual action: immediate occlusion on first use plus a cumulative effect with regular brushing. The mineral deposits densify and partially penetrate into the tubules, which is why relief builds over the first weeks of use and is maintained as application continues.

Efficacy

Strontium acetate's key advantage is speed. In a randomised clinical trial (West et al., 2013; pooled in PMC8493541), at 1 minute after application, 8% strontium acetate (Sensodyne Rapid Action) scored SCASS 1.57 ± 0.81. SCASS (Sensitivity Clinician Assessed Sensitivity Scale) is a scale on which a lower value means less sensitivity.

This is comparable to 8% arginine (Pro-Argin technology: SCASS 1.34 ± 0.68) and better than BioMin-F (2.03 ± 0.70) at that same first minute. So for instant relief, strontium acetate and arginine are roughly equal and both outpace bioglass at the start.

The honest dynamic picture matters too: by week 6 all three converge to a similar level (SCASS around 0.97). That means the main difference is in the speed of the first effect, not the final plateau. Trials also use the Schiff scale to assess the response to an air stimulus. The takeaway: strontium acetate is the pick where speed of onset is critical.

Safety

Stable strontium (Sr²⁺) is a non-radioactive isotope, unlike strontium-90, and has been used in sensitivity toothpastes for decades with a good safety profile. It is a routine, long-studied desensitiser approved by regulators for over-the-counter use.

The 8% concentration is the working, validated level: it delivers enough strontium-ion supply to form the apatite plug without excessive mineral loading. The acetate form is highly soluble and compatible with the fluorides and abrasives in a toothpaste base.

There are no special contraindications for healthy adults. Like all sensitivity products, strontium toothpastes are recommended for adults; if pain persists, it is important to rule out caries or a crack with a dentist, since a desensitiser masks the symptom but does not treat the structural cause.

Role in the QDRO formula

In the v.pro line for sensitive teeth, strontium acetate is the fast-acting partner for immediate relief. We view it as the form of choice where speed matters: occlusion begins from the first minute, not after weeks.

Honest positioning relative to the alternatives. Compared with strontium chloride, acetate delivers a faster onset at a lower concentration. Compared with arginine (Pro-Argin), the instant effect is comparable — both work through occlusion, and the choice between them is driven by formulation compatibility, not the superiority of one over the other. Compared with potassium nitrate, the difference is fundamental in mechanism: potassium calms the nerve, strontium seals the tubules — these are complementary, not competing, approaches.

The QDRO logic: occlusive strontium for an instant response, optionally in synergy with nano-hydroxyapatite for remineralisation. We claim only what is confirmed: relief from the first minute and a building effect with regular use.